Zorotene is a commercial drug that is prescribed in the form of Gel. It is primarily used for the treatment of Psoriasis. Zorotene also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Zorotene. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Zorotene side effects, there are can be others also. These have been listed below. These side effects of Zorotene are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Zorotene is Severe for pregnant women and Moderate for women who are breastfeeding. Further, the section on Zorotene related warnings talks about Zorotene's effects on the liver, heart and kidney.
Zorotene is not recommended if you suffer from certain medical conditions as it can have adverse effects. Eczema are examples of such conditions. Some other conditions that can be affected by Zorotene are listed in the contraindications section below.
Besides this, Zorotene may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Zorotene is safe while driving, and is is addictive in nature.
Zorotene is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Zorotene is used -
Moderate
Mild
Is the use of Zorotene safe for pregnant women?
Zorotene has many dangerous side effects in pregnant women. If you are pregnant, do not consume Zorotene without medical advice.
Is the use of Zorotene safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Zorotene. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Zorotene on the Kidneys?
Zorotene is completely safe for kidneys.
What is the effect of Zorotene on the Liver?
Zorotene may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Zorotene on the Heart?
No research work has been carried out till date on effects of Zorotene on heart. So it is not known whether taking Zorotene will cause side effects on heart or not.
Zorotene should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Zorotene unless your doctor advises you to do so -
Is this Zorotene habit forming or addictive?
Forming a habit of Zorotene has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Zorotene since it does not cause drowsiness.
Is it safe?
Zorotene should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Zorotene in mental disorders is not effective.
Interaction between Food and Zorotene
There isn't any research available on the side effects of taking Zorotene with food.
Interaction between Alcohol and Zorotene
It is difficult to say anything about the effect of Zorotene and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tazorac® (tazarotene)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 891